193 related articles for article (PubMed ID: 19190778)
1. Adhesion of human probiotic Lactobacillus rhamnosus to cervical and vaginal cells and interaction with vaginosis-associated pathogens.
Coudeyras S; Jugie G; Vermerie M; Forestier C
Infect Dis Obstet Gynecol; 2008; 2008():549640. PubMed ID: 19190778
[TBL] [Abstract][Full Text] [Related]
2. Lactobacillus strains isolated from the vaginal microbiota of healthy women inhibit Prevotella bivia and Gardnerella vaginalis in coculture and cell culture.
Atassi F; Brassart D; Grob P; Graf F; Servin AL
FEMS Immunol Med Microbiol; 2006 Dec; 48(3):424-32. PubMed ID: 17059467
[TBL] [Abstract][Full Text] [Related]
3. Lacticaseibacillus rhamnosus Lcr35 Stimulates Epithelial Vaginal Defenses upon Gardnerella vaginalis Infection.
Miquel S; Verlaguet J; Garcin S; Bertran T; Evrard B; Forestier C; Vareille-Delarbre M
Infect Immun; 2022 Sep; 90(9):e0030922. PubMed ID: 36000874
[TBL] [Abstract][Full Text] [Related]
4. [GynOphilus--a winning relay].
Kovachev S
Akush Ginekol (Sofiia); 2012; 51 Suppl 1():41-4. PubMed ID: 23236678
[TBL] [Abstract][Full Text] [Related]
5. In vitro antibacterial activity of Lactobacillus helveticus strain KS300 against diarrhoeagenic, uropathogenic and vaginosis-associated bacteria.
Atassi F; Brassart D; Grob P; Graf F; Servin AL
J Appl Microbiol; 2006 Sep; 101(3):647-54. PubMed ID: 16907815
[TBL] [Abstract][Full Text] [Related]
6. Characterization and complete genome sequences of L. rhamnosus DSM 14870 and L. gasseri DSM 14869 contained in the EcoVag
Marcotte H; Krogh Andersen K; Lin Y; Zuo F; Zeng Z; Larsson PG; Brandsborg E; Brønstad G; Hammarström L
Microbiol Res; 2017 Dec; 205():88-98. PubMed ID: 28942850
[TBL] [Abstract][Full Text] [Related]
7. Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus La-14 Attenuate Gardnerella vaginalis-Infected Bacterial Vaginosis in Mice.
Jang SE; Jeong JJ; Choi SY; Kim H; Han MJ; Kim DH
Nutrients; 2017 May; 9(6):. PubMed ID: 28545241
[TBL] [Abstract][Full Text] [Related]
8. In vitro inhibitory activity of human vaginal lactobacilli against pathogenic bacteria associated with bacterial vaginosis in Kenyan women.
Matu MN; Orinda GO; Njagi EN; Cohen CR; Bukusi EA
Anaerobe; 2010 Jun; 16(3):210-5. PubMed ID: 19925874
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial and inflammatory properties of South African clinical Lactobacillus isolates and vaginal probiotics.
Chetwin E; Manhanzva MT; Abrahams AG; Froissart R; Gamieldien H; Jaspan H; Jaumdally SZ; Barnabas SL; Dabee S; Happel AU; Bowers D; Davids L; Passmore JS; Masson L
Sci Rep; 2019 Feb; 9(1):1917. PubMed ID: 30760770
[TBL] [Abstract][Full Text] [Related]
10. Lactobacillus johnsonii HY7042 ameliorates Gardnerella vaginalis-induced vaginosis by killing Gardnerella vaginalis and inhibiting NF-κB activation.
Joo HM; Hyun YJ; Myoung KS; Ahn YT; Lee JH; Huh CS; Han MJ; Kim DH
Int Immunopharmacol; 2011 Nov; 11(11):1758-65. PubMed ID: 21798373
[TBL] [Abstract][Full Text] [Related]
11. An Updated Conceptual Model on the Pathogenesis of Bacterial Vaginosis.
Muzny CA; Taylor CM; Swords WE; Tamhane A; Chattopadhyay D; Cerca N; Schwebke JR
J Infect Dis; 2019 Sep; 220(9):1399-1405. PubMed ID: 31369673
[TBL] [Abstract][Full Text] [Related]
12. Effect of Lactobacillus challenge on Gardnerella vaginalis biofilms.
Saunders S; Bocking A; Challis J; Reid G
Colloids Surf B Biointerfaces; 2007 Apr; 55(2):138-42. PubMed ID: 17234391
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of antipathogenic activity and adherence properties of human Lactobacillus strains for vaginal formulations.
Verdenelli MC; Coman MM; Cecchini C; Silvi S; Orpianesi C; Cresci A
J Appl Microbiol; 2014 May; 116(5):1297-307. PubMed ID: 24552173
[TBL] [Abstract][Full Text] [Related]
14. Probiotics for the treatment of women with bacterial vaginosis.
Falagas M; Betsi GI; Athanasiou S
Clin Microbiol Infect; 2007 Jul; 13(7):657-64. PubMed ID: 17633390
[TBL] [Abstract][Full Text] [Related]
15. Selection of Lactobacillus strains as potential probiotics for vaginitis treatment.
Santos CMA; Pires MCV; Leão TL; Hernández ZP; Rodriguez ML; Martins AKS; Miranda LS; Martins FS; Nicoli JR
Microbiology (Reading); 2016 Jul; 162(7):1195-1207. PubMed ID: 27154285
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial Substances and Mechanisms of Lactobacillus rhamnosus against Gardnerella vaginalis.
Huang YP; Shi JY; Luo SC; Xu SY; Zhang JD; Molnár I; Yang QQ; Zhang BB
Probiotics Antimicrob Proteins; 2023 Apr; 15(2):400-410. PubMed ID: 36459386
[TBL] [Abstract][Full Text] [Related]
17. A clinical pilot study on the effect of the probiotic Lacticaseibacillus rhamnosus TOM 22.8 strain in women with vaginal dysbiosis.
Pino A; Rapisarda AMC; Vitale SG; Cianci S; Caggia C; Randazzo CL; Cianci A
Sci Rep; 2021 Jan; 11(1):2592. PubMed ID: 33510271
[TBL] [Abstract][Full Text] [Related]
18. Probiotic interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the opportunistic fungal pathogen Candida albicans.
Köhler GA; Assefa S; Reid G
Infect Dis Obstet Gynecol; 2012; 2012():636474. PubMed ID: 22811591
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study.
Vicariotto F; Mogna L; Del Piano M
J Clin Gastroenterol; 2014; 48 Suppl 1():S106-12. PubMed ID: 25291116
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a commensal, symbiotic relationship between Gardnerella vaginalis and Prevotella bivia involving ammonia: potential significance for bacterial vaginosis.
Pybus V; Onderdonk AB
J Infect Dis; 1997 Feb; 175(2):406-13. PubMed ID: 9203662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
